In this installment, Imogen Fitt, an analyst at Signify Research focused on digital pathology and AI, shares the latest developments transforming the field. She discusses a groundbreaking partnership between Alpenglow Biosciences and VirDx to enhance MRI-based prostate cancer diagnostics with large-scale datasets. The implementation of Aiforia's AI tools at Institut Curie promises quicker diagnoses, while Moffitt Cancer Center's adoption of Pramana scanners signals a shift towards high-throughput pathology. Imogen also highlights the rising momentum for DICOM standards in healthcare.
12:56
forum Ask episode
web_stories AI Snips
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
High‑Throughput Scanners Include Cytology
Pramana's high-throughput scanners at Moffitt will support both histology and cytology, including blood smears and phased adoption through 2027.
Imogen Fitt highlights the rarity and clinical importance of including cytology and hematology in digital rollouts.
insights INSIGHT
Large‑Scale French Rollout As A Case Study
Dedalus' Diamic‑DeepUnity rollout across Bretagne/Normandie aims to unify LIS, imaging, AI, and tele‑expertise over seven years starting December 2025.
Imogen Fitt frames it as a major case study for large digital transitions in pathology.
insights INSIGHT
AI Pilots In France Backed By Public Funds
Institut Curie will use Aiforia's CE‑IVD clinical AI tools in routine pathology via a one‑year, ARS Île‑de‑France funded agreement.
Fitt views this as evidence of growing AI adoption in France driven by targeted funding.
Get the Snipd Podcast app to discover more snips from this episode
The October 2025 digital pathology roundup with Imogen Fitt of Signify Research is here. Recent activity in digital pathology and AI spans new partnerships, implementations, and product launches.
Partnerships:
Alpenglow Biosciences & VirDx: Collaborating to create large-scale 3D light-sheet microscopy datasets as ground truth for VirDx’s MRI-based prostate cancer diagnostics, using NVIDIA accelerated computing to tightly link radiology and pathology.
Aiforia & Siemens Healthineers (Finland): After a broader European deal, Aiforia signed a local co-marketing/sales agreement with Siemens Healthineers’ Finnish affiliate to drive AI adoption in Finnish pathology as part of precision diagnostics.
Implementations:
Institut Curie: Entered a one-year agreement, funded by ARS Île-de-France, to use Aiforia’s CE-IVD clinical AI tools in routine pathology to support faster, more consistent diagnoses.
One Dorset Pathology (NHS): Signed a 7-year managed equipment service to deploy FUJIFILM SYNAPSE® Pathology on AWS, integrating partners like Sysmex, Menarini, Ibex, Barco, and Augnito. The goal is 100% digital reporting and meeting the UK 10-day histology target by early 2026.
Moffitt Cancer Center: Will implement four Pramana high-throughput scanners to support clinical and research work, including cytology and blood smears, with phased adoption through 2027.
Ouest Pathologie & Dedalus: Planning the largest French roll-out of the integrated Diamic-DeepUnity LIS + imaging platform across Bretagne/Normandie via a 7-year plan starting December 2025, enabling AI, tele-expertise, and unified image management.
Product launches & integrations:
Aignostics Atlas H&E-TME: Now generally available, offering rapid, single-cell-level TME readouts and >5,000 metrics per image from routine H&E, initially targeting biopharma research.
Proscia & Primaa: Integrated a skin AI module into Proscia’s platform for mitoses, hotspots, perineural invasion, and margin metrics in dermatopathology.
PathPresenter: Its vendor-agnostic clinical viewer achieved CE-IVDR marking for primary diagnosis in Europe, complementing its FDA 510(k) and enabling broader EU clinical deployments.
Digital-Pathology-Today 